1. Home
  2. INVE vs MIST Comparison

INVE vs MIST Comparison

Compare INVE & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Identiv Inc.

INVE

Identiv Inc.

HOLD

Current Price

$2.61

Market Cap

62.9M

Sector

Technology

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.32

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVE
MIST
Founded
1990
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.9M
176.3M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
INVE
MIST
Price
$2.61
$1.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.50
$8.00
AVG Volume (30 Days)
270.2K
1.4M
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,219,000.00
N/A
Revenue This Year
$22.10
$2,915.14
Revenue Next Year
$20.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.21
N/A
52 Week Low
$2.43
$1.00
52 Week High
$5.30
$3.06

Technical Indicators

Market Signals
Indicator
INVE
MIST
Relative Strength Index (RSI) 26.28 45.54
Support Level $2.43 $1.20
Resistance Level $3.75 $1.42
Average True Range (ATR) 0.18 0.07
MACD -0.12 0.02
Stochastic Oscillator 11.18 54.55

Price Performance

Historical Comparison
INVE
MIST

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: